References
- Gornik HL, Persu A, Adlam D, et al. First international consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019;24(2):164–189. doi:10.1177/1358863X18821816
- Mizutani K, Itoh A, Sugioka K, Komatsu R, Naruko T, Yoshiyama M. Intravascular findings of fibromuscular dysplasia on optical coherence tomography. J Cardiol Cases. 2015;12(2):39–42. doi:10.1016/j.jccase.2015.03.009
- Olin JW, Gornik HL, Bacharach JM, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048–1078. doi:10.1161/01.cir.0000442577.96802.8c
- Gottsäter A, Lindblad B. Optimal management of renal artery fibromuscular dysplasia. Ther Clin Risk Manag. 2014;10:583. doi:10.2147/TCRM.S48746
- Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin P-F. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010;56(3):525–532. doi:10.1161/HYPERTENSIONAHA.110.152918
- Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg. 2008;48(4):865–871. doi:10.1016/j.jvs.2008.05.030
- Vance CJ, Taylor RN, Craven TE, Edwards MS, Corriere MA. Increased prevalence of preeclampsia among women undergoing procedural intervention for renal artery fibromuscular dysplasia. Ann Vasc Surg. 2015;29(6):1105–1110. doi:10.1016/j.avsg.2015.03.037
- Harrison EG, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. 1971;46(3):161–167.
- McCormack LJ, Poutasse EF, Meaney TF, Noto TJ Jr, Dustan HP. A pathologic-arteriographic correlation of renal arterial disease. Am Heart J. 1966;72(2):188–198. doi:10.1016/0002-8703(66)90442-X
- Kincaid OW, Davis GD, Hallermann FJ, Hunt JC. Fibromuscular dysplasia of the renal arteries: arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol. 1968;104(2):271–282. doi:10.2214/ajr.104.2.271
- Olin JW, Pierce M. Contemporary management of fibromuscular dysplasia. Curr Opin Cardiol. 2008;23(6):527–536. doi:10.1097/HCO.0b013e328313119a
- Savard S, Steichen O, Azarine A, Azizi M, Jeunemaitre X, Plouin P-F. Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation. 2012;126(25):3062–3069. doi:10.1161/CIRCULATIONAHA.112.117499
- Mann SJ, Sos TA. The cardiovascular outcomes in renal atherosclerotic lesions study and the future of renal artery stenting. J Clin Hypertens. 2014;16(3):162–165. doi:10.1111/jch.12270
- Edem E, Aksoy MN, Pabuccu MT, Tatlı E. Endovascular treatment of renal artery stenosis due to fibromuscular dysplasia-is stent implantation underused in this circumstance? Heart Views. 2016;17(2):69.
- Olin JW, Sealove BA. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg. 2011;53(3):826–836. doi:10.1016/j.jvs.2010.10.066
- Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary intima-media thickness by optical coherence tomography comparison with intravascular ultrasound. Circ J. 2005;69(8):903–907. doi:10.1253/circj.69.903
- Hao H, Fujii K, Shibuya M, et al. Different findings in a calcified nodule between histology and intravascular imaging such as intravascular ultrasound, optical coherence tomography, and coronary angioscopy. JACC Cardiovasc Interv. 2014;7(8):937–938. doi:10.1016/j.jcin.2013.12.212